BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16621643)

  • 1. In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase.
    Merritt JL; Matern D; Vockley J; Daniels J; Nguyen TV; Schowalter DB
    Mol Genet Metab; 2006 Aug; 88(4):351-8. PubMed ID: 16621643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
    Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
    Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human very-long-chain acyl-CoA dehydrogenase gene promoter region: a role for activator protein 2.
    Zhou Y; Kelly DP; Strauss AW; Sims H; Zhang Z
    Mol Genet Metab; 1999 Dec; 68(4):481-7. PubMed ID: 10607478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency.
    Yamaguchi S; Indo Y; Coates PM; Hashimoto T; Tanaka K
    Pediatr Res; 1993 Jul; 34(1):111-3. PubMed ID: 8356011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical correction of very long-chain acyl-CoA dehydrogenase deficiency following adeno-associated virus gene therapy.
    Merritt JL; Nguyen T; Daniels J; Matern D; Schowalter DB
    Mol Ther; 2009 Mar; 17(3):425-9. PubMed ID: 19156135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
    Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
    Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency.
    Spiekerkoetter U; Sun B; Zytkovicz T; Wanders R; Strauss AW; Wendel U
    J Pediatr; 2003 Sep; 143(3):335-42. PubMed ID: 14517516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.
    Aoyama T; Souri M; Ushikubo S; Kamijo T; Yamaguchi S; Kelley RI; Rhead WJ; Uetake K; Tanaka K; Hashimoto T
    J Clin Invest; 1995 Jun; 95(6):2465-73. PubMed ID: 7769092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro correction of medium chain acyl CoA dehydrogenase deficiency with a recombinant adenoviral vector.
    Schowalter DB; Matern D; Vockley J
    Mol Genet Metab; 2005 Jun; 85(2):88-95. PubMed ID: 15896652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of very long chain acyl-CoA dehydrogenase deficiency in three Israeli patients: identification of a complex mutant allele with P65L and K247Q mutations, the former being an exonic mutation causing exon 3 skipping.
    Watanabe H; Orii KE; Fukao T; Song XQ; Aoyama T; IJlst L; Ruiter J; Wanders RJ; Kondo N
    Hum Mutat; 2000; 15(5):430-8. PubMed ID: 10790204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl-CoA dehydrogenase 9 (ACAD 9) is the long-chain acyl-CoA dehydrogenase in human embryonic and fetal brain.
    Oey NA; Ruiter JP; Ijlst L; Attie-Bitach T; Vekemans M; Wanders RJ; Wijburg FA
    Biochem Biophys Res Commun; 2006 Jul; 346(1):33-7. PubMed ID: 16750164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
    Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
    Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation.
    Schuler AM; Gower BA; Matern D; Rinaldo P; Vockley J; Wood PA
    Mol Genet Metab; 2005 May; 85(1):7-11. PubMed ID: 15862275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of the mouse short-chain acyl-CoA dehydrogenase cDNA.
    Kelly CL; Hinsdale ME; Wood PA
    Genomics; 1993 Oct; 18(1):137-40. PubMed ID: 8276399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model.
    Zhao XJ; Mohsen AW; Mihalik S; Solo K; Aliu E; Shi H; Basu S; Kochersperger C; Van't Land C; Karunanidhi A; Coughlan KA; Siddiqui S; Rice LM; Hillier S; Guadagnin E; Giangrande PH; Martini PGV; Vockley J
    Mol Genet Metab; 2023 Jan; 138(1):106982. PubMed ID: 36580829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphic variant in the human electron transfer flavoprotein alpha-chain (alpha-T171) displays decreased thermal stability and is overrepresented in very-long-chain acyl-CoA dehydrogenase-deficient patients with mild childhood presentation.
    Bross P; Pedersen P; Winter V; Nyholm M; Johansen BN; Olsen RK; Corydon MJ; Andresen BS; Eiberg H; Kolvraa S; Gregersen N
    Mol Genet Metab; 1999 Jun; 67(2):138-47. PubMed ID: 10356313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic DNA organization of human mitochondrial very-long-chain acyl-CoA dehydrogenase and mutation analysis.
    Orii KO; Aoyama T; Souri M; Orii KE; Kondo N; Orii T; Hashimoto T
    Biochem Biophys Res Commun; 1995 Dec; 217(3):987-92. PubMed ID: 8554625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.